Keystone National Policy Dialogue on Expanded Access to Promising Therapeutic Drugs for HIV Infection and AIDS with Implications

At the request of governmental agencies, pharmaceutical companies, congressional staff, researchers and public interest groups involved with the AIDS crisis, as well as advocates for other life-threatening diseases, Keystone initiated a dialogue to clarify issues and explore consensus on public policy approaches to the expedited development for – and expanded pre-approval access to – promising therapeutic drugs for AIDS.  Key decision-makers, including those who actively participated in the project as well as others interested in the results, helped define the scope of the Dialogue, identify participants, and establish goals and objectives for this effort.  The resulting recommendations encompassed research integrity, implications for clinical trials, access for uninsured patients, and effective communication and education.

Contact:  Janesse Brewer

Return to Infectious Disease